Adult aggressive natural killer cell leukemia

American Journal of the Medical Sciences

Volumn 346, Issue 1, 2013, Pages 56-63

  Zhang, Hongyu ^a   Meng, Qinxiang ^a   Yin, Weihua ^a   Xu, Lei ^a   Lie, Liping ^a  

^a PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

Author keywords

Aggressive natural killer cell leukemia; Bone marrow biopsy; Immunohistochemistry; Prognosis

Indexed keywords

ASPARAGINASE; BILIRUBIN; CD2 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; LACTATE DEHYDROGENASE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ADULT; AGED; AGGRESSIVE NK CELL LEUKEMIA; BILIRUBIN BLOOD LEVEL; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CELL INFILTRATION; CLINICAL ARTICLE; CYTOGENETICS; DRUG RESPONSE; DRUG TOLERABILITY; EPSTEIN BARR VIRUS; FEMALE; FEVER; FOLLOW UP; HEPATOSPLENOMEGALY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INTERSTITIAL PNEUMONIA; JAUNDICE; LACTATE DEHYDROGENASE BLOOD LEVEL; LARGE GRANULAR LYMPHOCYTE; LIVER DYSFUNCTION; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; TREATMENT RESPONSE; TUMOR CELL;

EID: 84880238647     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3182764b59     Document Type: Review

References (20)

1. Chan WC, Link S, Mawle A, et al. Heterogeneity of large granular lymphocyte proliferations: Delineation of two major subtypes. Blood 1986;68:1142-53 (Pubitemid 17186394)
2. Fernandez LA, Pope B, Lee C, et al. Aggressive natural killer cell leukemia in an adult with establishment of an NK cell line. Blood 1986; 67:925-30 (Pubitemid 16116398)
3. Chan JKC, Quintanilla-Martinez L, Ferry JA, et al. Extranodal NK/T-cell lymphoma, nasal type. In: Swerdlow SH, Campo E, Harris NL, et al, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC; 2008. p. 285-8.
4. Chan JKC, Jaffe ES, Ralfkiaer E, et al. Aggressive NK-cell leukemia. In: Swerdlow SH, Campo E, Harris NL, et al, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC; 2008. p. 276-7.
5. Suzuki R. Treatment of advanced extranodal NK/T cell lymphoma, nasal-type and aggressive NK-cell leukemia. Int J Hematol 2010;92: 697-701
6. Ham MF, Ko YH. Natural killer cell neoplasm: Biology and pathology. Int J Hematol 2010;92:681-9.
7. Au WY, Pang A, Choy C, et al. Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients. Blood 2004;104:243-9. (Pubitemid 38879864)
8. Suzuki R, Suzumiya J, Nakamura S, et al. Aggressive natural killer cell leukemia revisited: Large granular lymphocyte leukemia of cytotoxic NK cells. Leukemia 2004;18:763-70 (Pubitemid 38500195)
9. Ryder J, Wang X, Bao L, et al. Aggressive natural killer cell leukemia: Report of a Chinese series and review of the literature. Int J Hematol 2007;85:18-25 (Pubitemid 46193285)
10. Sokol L, Loughran TP Jr. Large granular lymphocyte leukemia. Oncologist 2006;11:263-73
11. Semenzato G, Marino F, Zambello R. State of the art in natural killer cell malignancies. Int J Lab Hematol 2012;34:117-28
12. Hasserjian RP, Harris NL. NK-cell lymphomas and leukemias: A spectrum of tumors with variable manifestations and immunophenotype. Am J Clin Pathol 2007;127:860-8.
13. Oshimi K. Progress in understanding and managing natural killer cell malignancies. Br J Haematol 2007;139:532-44 (Pubitemid 350043813)
14. Makishima H, Ito T, Momose K, et al. Chemokine system and tissue infiltration in aggressive NK-cell leukemia. Leuk Res 2007;31:1237-45
15. Jaccard A, Gachard N, Marin B, et al. Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study. Blood 2011;117:1834-9.
16. Yamaguchi M, Kwong YL, Kim WS, et al. Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: The NK-Cell Tumor Study Group study. J Clin Oncol 2011;29:4410-6.
17. Jaccard A, Petit B, Girault S, et al. L-asparaginase-based treatment of 15 western patients with extranodal NK/T-cell lymphoma and leukemia and a review of the literature. Ann Oncol 2009;20:110-6.and a review of the literature
18. Ito T, Makishima H, Nakazawa H, et al. Promising approach for aggressive NK-cell leukaemia with allogeneic haematopoietic cell transplantation. Eur J Haematol 2008;81:107-11 (Pubitemid 352019633)
19. Sallah S, Wan JY, Nguyen NP. Treatment of refractory T-cell malignancies using gemcitabine. Br J Haematol 2001;113:185-7. (Pubitemid 32423320)
20. Zinzani PL, Venturini F, Stefoni V, et al. Gemcitabine as single agent in pretreated T-cell lymphoma patients: Evaluation of the long-term outcome. Ann Oncol 2010;21:860-3.